array(3) { ["company_details"]=> array(13) { ["name"]=> string(14) "ELEKTA LIMITED" ["slug"]=> string(23) "dbe4b-gb-elekta-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7" ["description"]=> string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more." ["address_street"]=> string(11) "Linac House" ["address_place"]=> string(7) "CRAWLEY" ["address_region"]=> NULL ["founding_date"]=> string(10) "1996-09-02" ["website_domain"]=> string(10) "elekta.com" ["website_url"]=> string(22) "https://www.elekta.com" ["industry_codes"]=> array(1) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" } ["employee_count"]=> int(820) ["article_count"]=> int(550) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(30) "Worse than expected for Elekta" ["snippet_en"]=> string(141) "Radiation therapy company Elekta reports an operating profit of SEK 485 million for the third quarter of the company's broken financial year." ["url"]=> string(82) "https://www.privataaffarer.se/placeringar/aktier/samre-an-vantat-for-elekta-Wi5O2/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/49e7e114-bde6-4a86-9816-9a19f8cab1a7" ["source"]=> string(17) "privataaffarer.se" ["publication_date"]=> string(10) "2024-02-29" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(18) "Financial Distress" } } [1]=> array(7) { ["title_en"]=> string(57) "Elekta's adjusted operating profit was below expectations" ["snippet_en"]=> string(108) "The medical technology company Elekta reports a turnover in line with expectations during the third quarter." ["url"]=> string(86) "https://www.affarsvarlden.se/artikel/elektas-justerade-rorelseresultat-under-forvantan" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b4758a82-1908-4f9f-b35f-13b3f887b1af" ["source"]=> string(16) "affarsvarlden.se" ["publication_date"]=> string(10) "2023-12-30" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [2]=> array(7) { ["title_en"]=> string(34) "Elekta crushes profit expectations" ["snippet_en"]=> string(160) "Radiation therapy company Elekta reports an adjusted operating profit of SEK 427 million for the first quarter of the company's broken financial year 2023/2024." ["url"]=> string(85) "https://www.privataaffarer.se/placeringar/aktier/elekta-krossar-vinstforvantningarna/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d846e1af-d7c3-4c5c-9fd4-6d85f1597b1a" ["source"]=> string(17) "privataaffarer.se" ["publication_date"]=> string(10) "2023-08-24" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Restatements" [2]=> string(24) "Quarterly/Annual Figures" } } [3]=> array(7) { ["title_en"]=> string(27) "Results crusher from Elekta" ["snippet_en"]=> string(253) "The medical technology company Elekta reports an interim report for the first quarter of the broken fiscal year 2023/2024 that beats analysts' expectations, especially around the adjusted operating profit. Net profit increased sharply during the period." ["url"]=> string(62) "https://www.aktiespararna.se/nyheter/resultatkross-fran-elekta" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f13f624b-e6c4-4377-9261-5930dbf55209" ["source"]=> string(16) "aktiespararna.se" ["publication_date"]=> string(10) "2023-08-24" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [4]=> array(7) { ["title_en"]=> string(38) "Elekta shatters expectations – again" ["snippet_en"]=> string(115) "Elekta's report exceeded expectations. The profit increases sharply and the stock continues to be considered a buy." ["url"]=> string(61) "https://www.di.se/analys/elekta-krossar-forvantningarna-igen/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2a6e4b50-3a64-4eed-adbb-6b62faefe5f9" ["source"]=> string(5) "di.se" ["publication_date"]=> string(10) "2023-08-24" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(24) "Quarterly/Annual Figures" } } [5]=> array(7) { ["title_en"]=> string(38) "Higher profit than expected for Elekta" ["snippet_en"]=> string(64) "Turnover and order intake were also higher than the advance tips" ["url"]=> string(63) "https://www.privataaffarer.se/hogre-vinst-an-vantat-for-elekta/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8aa0bd74-0c33-4198-a9d2-4101bb1c5967" ["source"]=> string(17) "privataaffarer.se" ["publication_date"]=> string(10) "2023-05-25" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(24) "Quarterly/Annual Figures" } } [6]=> array(7) { ["title_en"]=> string(59) "ZIGNSEC: EBITDA WAS SEK -5.6 MILLION 4 QUARTER, REVENUE -8%" ["snippet_en"]=> string(82) "Elekta rises strongly on report - Getinge at the bottom of the large company index" ["url"]=> string(90) "https://www.privataaffarer.se/zignsec-ebitda-blev-56-mln-kr-4-kv-omsattningen-8-1677229794" ["image_url"]=> NULL ["source"]=> string(17) "privataaffarer.se" ["publication_date"]=> string(10) "2023-02-02" ["categories"]=> array(1) { [0]=> string(24) "Quarterly/Annual Figures" } } [7]=> array(7) { ["title_en"]=> string(34) "Interim report, May–July 2020/21" ["snippet_en"]=> string(251) "Interim report, May–July 2020/21 Shows resilience The world is still affected by the covid-19 pandemic and so is our industry. But Elekta's solid results with positive order growth and increased profitability during the first quarter is a clear sign" ["url"]=> string(84) "https://www.elekta.com/pressreleases/FA2EEFACC44341F9/delarsrapport-maj-juli-2020-21" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4000d557-cf06-483d-97e2-d3b7b572d7cd" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2020-07-01" ["categories"]=> array(2) { [0]=> string(8) "Epidemic" [1]=> string(24) "Quarterly/Annual Figures" } } [8]=> array(7) { ["title_en"]=> string(37) "Interim report, May–January 2020/21" ["snippet_en"]=> string(242) "Interim report, May–January 2020/21 Momentum and growth During Elekta's third quarter, we experienced an improved market situation and gained increased access to customers. Both orders and revenue recovered and we returned to growth. Elekta" ["url"]=> string(87) "https://www.elekta.com/pressreleases/2BEE8878CDA891D7/delarsrapport-maj-januari-2020-21" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fe8a115b-f280-47f2-ae59-6ff1a421e6ae" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2020-01-01" ["categories"]=> array(1) { [0]=> string(24) "Quarterly/Annual Figures" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(35) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(25) } [2]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(23) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(19) } [4]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(16) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(15) } [7]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [8]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(11) } [9]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(11) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(11) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(9) } [12]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(8) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [14]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(6) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(6) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(6) } [17]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(6) } [18]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [19]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(5) } [20]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [21]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(4) } [22]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(4) } [23]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(4) } [24]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(4) } [25]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(3) } [26]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(3) } [27]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(3) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(2) } } } dbe4b-gb-elekta-limited

ELEKTA LIMITED

Location

Founded

1996-09-02

Website

https://www.elekta.com

Articles

550 Articles

Category

Surgical and Medical Instruments and Apparatus

Description

At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.

Articles

Worse than expected for Elekta

2024-02-29 (privataaffarer.se)

Worse than expected for Elekta

Radiation therapy company Elekta reports an operating profit of SEK 485 million for the third quarter of the company's broken financial year.

Read more
Elekta's adjusted operating profit was below expectations

2023-12-30 (affarsvarlden.se)

Elekta's adjusted operating profit was below expectations

The medical technology company Elekta reports a turnover in line with expectations during the third quarter.

Read more
Elekta crushes profit expectations

2023-08-24 (privataaffarer.se)

Elekta crushes profit expectations

Radiation therapy company Elekta reports an adjusted operating profit of SEK 427 million for the first quarter of the company's broken financial year 2023/2024.

Read more
Results crusher from Elekta

2023-08-24 (aktiespararna.se)

Results crusher from Elekta

The medical technology company Elekta reports an interim report for the first quarter of the broken fiscal year 2023/2024 that beats analysts' expectations, especially around the adjusted operating profit. Net profit increased sharply during the period.

Read more
Elekta shatters expectations – again

2023-08-24 (di.se)

Elekta shatters expectations – again

Elekta's report exceeded expectations. The profit increases sharply and the stock continues to be considered a buy.

Read more
Higher profit than expected for Elekta

2023-05-25 (privataaffarer.se)

Higher profit than expected for Elekta

Turnover and order intake were also higher than the advance tips

Read more
ZIGNSEC: EBITDA WAS SEK -5.6 MILLION 4 QUARTER, REVENUE -8%

2023-02-02 (privataaffarer.se)

ZIGNSEC: EBITDA WAS SEK -5.6 MILLION 4 QUARTER, REVENUE -8%

Elekta rises strongly on report - Getinge at the bottom of the large company index

Read more
Interim report, May–July 2020/21

2020-07-01 (elekta.com)

Interim report, May–July 2020/21

Interim report, May–July 2020/21 Shows resilience The world is still affected by the covid-19 pandemic and so is our industry. But Elekta's solid results with positive order growth and increased profitability during the first quarter is a clear sign

Read more
Interim report, May–January 2020/21

2020-01-01 (elekta.com)

Interim report, May–January 2020/21

Interim report, May–January 2020/21 Momentum and growth During Elekta's third quarter, we experienced an improved market situation and gained increased access to customers. Both orders and revenue recovered and we returned to growth. Elekta

Read more

Newsletter subscription